Physician profile
David E Weaver
NPI 1609836279
$8,061.09
in general payments reported to CMS, 2019-2025
27 companies · $3,129 in 2025
The $3,129 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $50.19 · 2021: $295 · 2022: $2,206 · 2023: $808 · 2024: $444 · 2025: $3,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,948 · Travel and Lodging: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,948.18 |
| Travel and Lodging | $1,432.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,085.42 | 2019-2025 | Indigo System |
| Medtronic, INC. | $1,330.62 | 2021-2022 | |
| Inari Medical, INC. | $1,162.75 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $558.61 | 2019-2025 | Avvigo Guidance System, Ekosonic, Comet |
| Abbott Laboratories | $425.81 | 2021-2025 | Optis, Amplatzer Amulet, Mitraclip |
| Cordis US Corp. | $239.87 | 2025 | |
| Abiomed | $222.17 | 2020-2024 | Impella |
| Shockwave Medical, INC | $222.13 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $149.01 | 2021-2022 | |
| Novo Nordisk INC | $112.68 | 2025 | Wegovy |
| Stryker Corporation | $92.62 | 2025 | Flowtriever, Artix Mt, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $61.48 | 2019-2020 | |
| Chiesi USA, INC. | $51.01 | 2021-2022 | |
| Pfizer INC. | $46.78 | 2022-2024 | |
| Terumo Medical Corporation | $40.82 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.95 | 2019-2022 | |
| Heartflow, INC. | $31.08 | 2022 | |
| Recor Medical INC | $25.12 | 2024 | Paradise Renal Denervation System |
| Alnylam Pharmaceuticals INC. | $24.67 | 2025 | Amvuttra |
| Cardiovascular Systems INC. | $21.36 | 2022-2023 | Diamondback Coronary |
| Edwards Lifesciences Corporation | $18.87 | 2025 | |
| Irhythm Technologies, INC. | $18.59 | 2023 | Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $18.12 | 2023 | Livalo |
| Masimo Corporation | $17.34 | 2023 | Patient Safetynet System, Set and Rainbow Set |
| Janssen Pharmaceuticals, INC | $16.16 | 2023 | Xarelto |
| Biotronik INC. | $15.56 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.49 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.